CHRONOSCALE (CHRN) Extends $2M B. Riley Note, Clears Path to Sell Ekso Bionics
An amendment pushes the maturity of a $2 million secured note to November 12, 2026 and makes a sale of the Ekso Bionics unit a permitted disposition.
ChronoScale Holdings (CHRN) has amended a $2 million secured promissory note with B. Riley Commercial Capital, extending the maturity date to November 12, 2026 and carving out a sale of its Ekso Bionics subsidiary as a Permitted Disposition. The amendment was entered into as of September 12, 2026 and disclosed in an 8-K covering the entry into a material agreement.
